Research focuses on induced pluripotent stem (iPS) cell reprogramming for developing innovative treatments for challenging diseases and degenerative conditions.
Direct conversion of cells to generate patient-specific stem cells for therapeutic applications and disease treatment.
Development and utilization of 3D organoid structures that resemble real tissues to simulate disease progression and explore treatment strategies in human tissue-like environments.
Application of stem cell and organoid technologies for innovative drug screening and toxicity testing approaches.
Collaboration with Max Planck Institute for Molecular Biomedicine
출처: 연구실 홈페이지
현재 재학생
6명
최근 5년 졸업
수집 중
수집 중
수집 중
논문 데이터가 수집되면 연구 키워드가 자동 추출됩니다